Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERDAFITINIB vs ERTAPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERDAFITINIB vs ERTAPENEM: Safety Overview

Metric ERDAFITINIB ERTAPENEM
Total FAERS Reports 1,106 4,069
Deaths Reported 315 223
Death Rate 28.5% 5.5%
Hospitalizations 226 1,617
Average Patient Age 66.6 yrs 64.1 yrs
% Female Patients 37.9% 54.5%
FDA Approval Date Apr 12, 2019 Apr 16, 2018
Manufacturer Janssen Products LP Merck Sharp & Dohme LLC
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription